Systematic Review and Meta‐Analysis: Bismuth Enhances the Efficacy for Eradication of Helicobacter pylori
Helicobacter · 2024
DOI: 10.1111/hel.13141 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Helicobacter, 2024. Verfasst von A Reum Choe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bismuth, Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This work was supported by the Ewha Womans University Research Grant of 2021.
Abstract (Originalsprache)
Background
In the eradication of Helicobacter pylori , the efficacy of bismuth remains inconclusive. We aimed to compare the efficacy of bismuth on various H. pylori eradication regimens.
Methods
Randomized controlled trials were collected to compare the efficacy of bismuth to nonbismuth regimens in H. pylori eradication. We pooled information to study eradication, adverse events, and drug compliance. In addition, subgroup analyses for eradication efficacy were performed according to high or low clarithromycin‐resistance area, bismuth drug form, and amount of bismuth element.
Results
Records for a total of 2506 patients in 15 trials from 13 randomized controlled studies were included. The eradication of H. pylori was superior when bismuth compared to nonbismuth regimen (odds ratio [OR] = 1.63, 95% confidence interval [CI], 1.33–2.00 in intention‐to‐treat [ITT]; OR = 2.05, 95% CI, 1.58–2.68 in per‐protocol [PP] analyses), without significant difference in drug compliance or adverse events. Bismuth regimens in the high clarithromycin resistance area tend to enhance the eradication rate (OR = 1.66, 95% CI, 1.34–2.05 in ITT; OR = 2.22, 95% CI, 1.67–2.95 in PP analyses). Bismuth potassium citrate and bismuth subcitrate were more effective drug forms in regard to eradication rate. Bismuth at a dosage of < 500 mg/day was significantly higher for the eradication rate.
Conclusions
Bismuth to the H. pylori eradication regimens achieve a higher eradication rate, especially in the high clarithromycin resistance area. It could be an eradication option achieving sufficient resistance rates without increasing antibiotic resistance, side effects, or poor compliance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea.
- Division of Health Technology Assessment Research, National Evidence-Based Healthcare Collaborating Agency, Seoul, Korea.
ORCID-Profile: A Reum Choe, Chung Hyun Tae, Miyoung Choi, Ki-Nam Shim, Hye-Kyung Jung
Förderung
- This work was supported by the Ewha Womans University Research Grant of 2021
Zitieren
APA
Reum Choe, A., Tae, C. H., Choi, M., Shim, K. N., & Jung, H. K. (2024). Systematic Review and Meta‐Analysis: Bismuth Enhances the Efficacy for Eradication of Helicobacter pylori. Helicobacter. https://doi.org/10.1111/hel.13141
Vancouver
Reum Choe A, Tae CH, Choi M, Shim KN, Jung HK. Systematic Review and Meta‐Analysis: Bismuth Enhances the Efficacy for Eradication of Helicobacter pylori. Helicobacter. 2024. doi:10.1111/hel.13141
BibTeX
@article{ReumChoe2024,
author = {Reum Choe, A and Tae, Chung Hyun and Choi, Miyoung and Shim, Ki-Nam and Jung, Hye-Kyung},
title = {Systematic Review and Meta‐Analysis: Bismuth Enhances the Efficacy for Eradication of Helicobacter pylori},
journal = {Helicobacter},
year = {2024},
doi = {10.1111/hel.13141}
}
EUVIMED